Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Aug, 2014 | Pages:
651 | Publisher: Global Markets Direct
Industry: Healthcare | Report Format: Electronic (PDF)
Asthma - Pipeline Review, H2 2014 Summary Global Markets Direct's, 'Asthma - Pipeline Review, H2 2014', provides an overview of the Asthma's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Asthma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Asthma and special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides a snapshot of the global therapeutic landscape of Asthma - The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities - The report reviews key players involved in the therapeutics development for Asthma and enlists all their major and minor projects - The report summarizes all the dormant and discontinued pipeline projects - A review of the Asthma products under development by companies and universities/research institutes based on information derived from company and industry-specific sources - Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages - A detailed assessment of monotherapy and combination therapy pipeline projects - Coverage of the Asthma pipeline on the basis of target, MoA, route of administration and molecule type - Latest news and deals relating related to pipeline products Reasons to buy - Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Develop strategic initiatives by understanding the focus areas of leading companies - Identify and understand important and diverse types of therapeutics under development for Asthma - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Devise corrective measures for pipeline projects by understanding Asthma pipeline depth and focus of Indication therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
Table of Contents Table of Contents 2 Introduction 8 Asthma Overview 9 Therapeutics Development 10 Asthma - Therapeutics under Development by Companies 12 Asthma - Therapeutics under Investigation by Universities/Institutes 23 Asthma - Pipeline Products Glance 25 Asthma - Products under Development by Companies 29 Asthma - Products under Investigation by Universities/Institutes 44 Asthma - Companies Involved in Therapeutics Development 45 Asthma - Therapeutics Assessment 169 Drug Profiles 188 Asthma - Recent Pipeline Updates 518 Asthma - Dormant Projects 595 Asthma - Discontinued Products 617 Appendix 623
List of Tables Number of Products under Development for Asthma, H2 2014 37 Number of Products under Development for Asthma - Comparative Analysis, H2 2014 38 Number of Products under Development by Companies, H2 2014 40 Number of Products under Development by Companies, H2 2014 (Contd..1) 41 Number of Products under Development by Companies, H2 2014 (Contd..2) 42 Number of Products under Development by Companies, H2 2014 (Contd..3) 43 Number of Products under Development by Companies, H2 2014 (Contd..4) 44 Number of Products under Development by Companies, H2 2014 (Contd..5) 45 Number of Products under Development by Companies, H2 2014 (Contd..6) 46 Number of Products under Development by Companies, H2 2014 (Contd..7) 47 Number of Products under Development by Companies, H2 2014 (Contd..8) 48 Number of Products under Development by Companies, H2 2014 (Contd..9) 49 Number of Products under Investigation by Universities/Institutes, H2 2014 51 Comparative Analysis by Late Stage Development, H2 2014 52 Comparative Analysis by Clinical Stage Development, H2 2014 53 Comparative Analysis by Early Stage Development, H2 2014 54 Comparative Analysis by Unknown Stage Development, H2 2014 55 Products under Development by Companies, H2 2014 56 Products under Development by Companies, H2 2014 (Contd..1) 57 Products under Development by Companies, H2 2014 (Contd..2) 58 Products under Development by Companies, H2 2014 (Contd..3) 59 Products under Development by Companies, H2 2014 (Contd..4) 60 Products under Development by Companies, H2 2014 (Contd..5) 61 Products under Development by Companies, H2 2014 (Contd..6) 62 Products under Development by Companies, H2 2014 (Contd..7) 63 Products under Development by Companies, H2 2014 (Contd..8) 64 Products under Development by Companies, H2 2014 (Contd..9) 65 Products under Development by Companies, H2 2014 (Contd..10) 66 Products under Development by Companies, H2 2014 (Contd..11) 67 Products under Development by Companies, H2 2014 (Contd..12) 68 Products under Development by Companies, H2 2014 (Contd..13) 69 Products under Development by Companies, H2 2014 (Contd..14) 70 Products under Investigation by Universities/Institutes, H2 2014 71 Asthma - Pipeline by Johnson & Johnson, H2 2014 72 Asthma - Pipeline by Boehringer Ingelheim GmbH, H2 2014 73 Asthma - Pipeline by F. Hoffmann-La Roche Ltd., H2 2014 74 Asthma - Pipeline by Kyowa Hakko Kirin Co., Ltd., H2 2014 75 Asthma - Pipeline by Amgen Inc., H2 2014 76 Asthma - Pipeline by AstraZeneca PLC, H2 2014 77 Asthma - Pipeline by GlaxoSmithKline plc, H2 2014 78 Asthma - Pipeline by Genentech, Inc., H2 2014 79 Asthma - Pipeline by Biotec Pharmacon ASA, H2 2014 80 Asthma - Pipeline by MedImmune, LLC, H2 2014 81 Asthma - Pipeline by Daiichi Sankyo Company, Limited, H2 2014 82 Asthma - Pipeline by Merck & Co., Inc., H2 2014 83 Asthma - Pipeline by Nissan Chemical Industries, Ltd., H2 2014 84 Asthma - Pipeline by Sumitomo Dainippon Pharma Co., Ltd., H2 2014 85 Asthma - Pipeline by Takeda Pharmaceutical Company Limited, H2 2014 86 Asthma - Pipeline by SkyePharma PLC, H2 2014 87 Asthma - Pipeline by Vectura Group plc, H2 2014 88 Asthma - Pipeline by BioLineRx, Ltd., H2 2014 89 Asthma - Pipeline by Hanwha Chemical Co., Ltd., H2 2014 90 Asthma - Pipeline by Novartis AG, H2 2014 91 Asthma - Pipeline by Actelion Ltd, H2 2014 92 Asthma - Pipeline by Astellas Pharma Inc., H2 2014 93 Asthma - Pipeline by Chiesi Farmaceutici SpA, H2 2014 94 Asthma - Pipeline by Glenmark Pharmaceuticals Ltd., H2 2014 95 Asthma - Pipeline by Kissei Pharmaceutical Co., Ltd., H2 2014 96 Asthma - Pipeline by Laboratoires Pierre Fabre SA, H2 2014 97 Asthma - Pipeline by Mitsubishi Tanabe Pharma Corporation, H2 2014 98 Asthma - Pipeline by Ono Pharmaceutical Co., Ltd., H2 2014 99 Asthma - Pipeline by Orion Corp, H2 2014 100 Asthma - Pipeline by Pfizer Inc., H2 2014 101 Asthma - Pipeline by SK Chemicals Co., Ltd., H2 2014 102 Asthma - Pipeline by Teva Pharmaceutical Industries Limited, H2 2014 103 Asthma - Pipeline by Zambon Company S.p.A., H2 2014 104 Asthma - Pipeline by OPKO Health, Inc., H2 2014 105 Asthma - Pipeline by iCo Therapeutics Inc., H2 2014 106 Asthma - Pipeline by Antisense Therapeutics Limited, H2 2014 107 Asthma - Pipeline by Almirall, S.A., H2 2014 108 Asthma - Pipeline by Lpath, Inc., H2 2014 109 Asthma - Pipeline by Basilea Pharmaceutica AG, H2 2014 110 Asthma - Pipeline by Mesoblast Limited, H2 2014 111 Asthma - Pipeline by Orchid Chemicals & Pharmaceuticals Ltd, H2 2014 112 Asthma - Pipeline by Palatin Technologies, Inc., H2 2014 113 Asthma - Pipeline by Pharmaxis Limited, H2 2014 114 Asthma - Pipeline by CSL Limited, H2 2014 115 Asthma - Pipeline by Cytokinetics, Inc., H2 2014 116 Asthma - Pipeline by Yungjin Pharm Ind. Co., Ltd., H2 2014 117 Asthma - Pipeline by Yuhan Corporation, H2 2014 118 Asthma - Pipeline by WhanIn Pharmaceutical Co., Ltd., H2 2014 119 Asthma - Pipeline by Regeneron Pharmaceuticals, Inc., H2 2014 120 Asthma - Pipeline by NeoStem, Inc., H2 2014 121 Asthma - Pipeline by Dynavax Technologies Corporation, H2 2014 122 Asthma - Pipeline by Ahn-Gook Pharmaceutical Co., Ltd., H2 2014 123 Asthma - Pipeline by Verona Pharma Plc, H2 2014 124 Asthma - Pipeline by Morphotek, Inc., H2 2014 125 Asthma - Pipeline by Alba Therapeutics Corporation, H2 2014 126 Asthma - Pipeline by Immupharma Plc, H2 2014 127 Asthma - Pipeline by Farmacija d.o.o. Tuzla, H2 2014 128 Asthma - Pipeline by Pieris AG, H2 2014 129 Asthma - Pipeline by Respiratorius AB, H2 2014 130 Asthma - Pipeline by Hutchison MediPharma Limited, H2 2014 131 Asthma - Pipeline by Aquinox Pharmaceuticals Inc., H2 2014 132 Asthma - Pipeline by Proteologics Ltd., H2 2014 133 Asthma - Pipeline by AnaptysBio, Inc., H2 2014 134 Asthma - Pipeline by Circassia Holdings Ltd., H2 2014 135 Asthma - Pipeline by Nostrum Pharmaceuticals, LLC, H2 2014 136 Asthma - Pipeline by Promedior, Inc., H2 2014 137 Asthma - Pipeline by Oxagen Limited, H2 2014 138 Asthma - Pipeline by Pulmatrix, Inc., H2 2014 139 Asthma - Pipeline by Axikin Pharmaceuticals, Inc., H2 2014 140 Asthma - Pipeline by MSM Protein Technologies, Inc., H2 2014 141 Asthma - Pipeline by Rottapharm SpA, H2 2014 142 Asthma - Pipeline by Hydra Biosciences, Inc., H2 2014 143 Asthma - Pipeline by Theraclone Sciences, Inc., H2 2014 144 Asthma - Pipeline by Polyphor Ltd., H2 2014 145 Asthma - Pipeline by Monosol Rx, LLC, H2 2014 146 Asthma - Pipeline by Omeros Corporation, H2 2014 147 Asthma - Pipeline by Xencor, Inc., H2 2014 148 Asthma - Pipeline by Sparsha Pharma International Pvt. Ltd., H2 2014 149 Asthma - Pipeline by Cellceutix Corporation, H2 2014 150 Asthma - Pipeline by Invion Limited, H2 2014 151 Asthma - Pipeline by AB Science, H2 2014 152 Asthma - Pipeline by Vitae Pharmaceuticals, Inc., H2 2014 153 Asthma - Pipeline by Adamis Pharmaceuticals Corporation, H2 2014 154 Asthma - Pipeline by Asmacure Ltee, H2 2014 155 Asthma - Pipeline by CalciMedica, Inc., H2 2014 156 Asthma - Pipeline by ISU ABXIS Co.,Ltd., H2 2014 157 Asthma - Pipeline by Receptos, Inc., H2 2014 158 Asthma - Pipeline by KAEL-GemVax Co., Ltd., H2 2014 159 Asthma - Pipeline by Afferent Pharmaceuticals, Inc., H2 2014 160 Asthma - Pipeline by iCeutica, Inc., H2 2014 161 Asthma - Pipeline by Histocell S.L., H2 2014 162 Asthma - Pipeline by GlycoMar Limited, H2 2014 163 Asthma - Pipeline by Cognosci, Inc., H2 2014 164 Asthma - Pipeline by LegoChem Biosciences, Inc, H2 2014 165 Asthma - Pipeline by Trimel BioPharma SRL, H2 2014 166 Asthma - Pipeline by Jiangsu Hansoh Pharmaceutical Co., Ltd., H2 2014 167 Asthma - Pipeline by Fountain Biopharma Inc., H2 2014 168 Asthma - Pipeline by Clarassance, Inc., H2 2014 169 Asthma - Pipeline by Spring Bank Pharmaceuticals, Inc., H2 2014 170 Asthma - Pipeline by Apellis Pharmaceuticals, Inc., H2 2014 171 Asthma - Pipeline by Prosonix Ltd, H2 2014 172 Asthma - Pipeline by Corridor Pharmaceuticals Inc., H2 2014 173 Asthma - Pipeline by Amakem NV, H2 2014 174 Asthma - Pipeline by centrose llc, H2 2014 175 Asthma - Pipeline by Sunovion Pharmaceuticals Inc., H2 2014 176 Asthma - Pipeline by NeoPharm Co., Ltd., H2 2014 177 Asthma - Pipeline by Hanmi Pharmaceuticals, Co. Ltd., H2 2014 178 Asthma - Pipeline by Lead Discovery Center GmbH, H2 2014 179 Asthma - Pipeline by Griffin Discoveries BV, H2 2014 180 Asthma - Pipeline by PharmaLundensis AB, H2 2014 181 Asthma - Pipeline by High Point Pharmaceuticals, LLC, H2 2014 182 Asthma - Pipeline by Visionary Pharmaceuticals, Inc., H2 2014 183 Asthma - Pipeline by Qu Biologics Inc., H2 2014 184 Asthma - Pipeline by Incozen Therapeutics Pvt Ltd, H2 2014 185 Asthma - Pipeline by sterna biologicals Gmbh & Co KG, H2 2014 186 Asthma - Pipeline by Rhizen Pharmaceuticals SA, H2 2014 187 Asthma - Pipeline by ARA Healthcare Pvt. Ltd., H2 2014 188 Asthma - Pipeline by Panmira Pharmaceuticals, LLC., H2 2014 189 Asthma - Pipeline by ReveraGen BioPharma, Inc., H2 2014 190 Asthma - Pipeline by Agilvax, Inc., H2 2014 191 Asthma - Pipeline by Foresee Pharmaceuticals, LLC, H2 2014 192 Asthma - Pipeline by Ziarco Pharma Ltd, H2 2014 193 Asthma - Pipeline by Cellular Biomedicine Group, Inc., H2 2014 194 Asthma - Pipeline by INOXIA Lifesciences GmbH, H2 2014 195 Assessment by Monotherapy Products, H2 2014 196 Assessment by Combination Products, H2 2014 197 Number of Products by Stage and Target, H2 2014 200 Number of Products by Stage and Mechanism of Action, H2 2014 206 Number of Products by Stage and Route of Administration, H2 2014 211 Number of Products by Stage and Molecule Type, H2 2014 214 Asthma Therapeutics - Recent Pipeline Updates, H2 2014 545 Asthma - Dormant Projects, H2 2014 622 Asthma - Dormant Projects (Contd..1), H2 2014 623 Asthma - Dormant Projects (Contd..2), H2 2014 624 Asthma - Dormant Projects (Contd..3), H2 2014 625 Asthma - Dormant Projects (Contd..4), H2 2014 626 Asthma - Dormant Projects (Contd..5), H2 2014 627 Asthma - Dormant Projects (Contd..6), H2 2014 628 Asthma - Dormant Projects (Contd..7), H2 2014 629 Asthma - Dormant Projects (Contd..8), H2 2014 630 Asthma - Dormant Projects (Contd..9), H2 2014 631 Asthma - Dormant Projects (Contd..10), H2 2014 632 Asthma - Dormant Projects (Contd..11), H2 2014 633 Asthma - Dormant Projects (Contd..12), H2 2014 634 Asthma - Dormant Projects (Contd..13), H2 2014 635 Asthma - Dormant Projects (Contd..14), H2 2014 636 Asthma - Dormant Projects (Contd..15), H2 2014 637 Asthma - Dormant Projects (Contd..16), H2 2014 638 Asthma - Dormant Projects (Contd..17), H2 2014 639 Asthma - Dormant Projects (Contd..18), H2 2014 640 Asthma - Dormant Projects (Contd..19), H2 2014 641 Asthma - Dormant Projects (Contd..20), H2 2014 642 Asthma - Dormant Projects (Contd..21), H2 2014 643 Asthma - Discontinued Products, H2 2014 644 Asthma - Discontinued Products (Contd..1), H2 2014 645 Asthma - Discontinued Products (Contd..2), H2 2014 646 Asthma - Discontinued Products (Contd..3), H2 2014 647 Asthma - Discontinued Products (Contd..4), H2 2014 648 Asthma - Discontinued Products (Contd..5), H2 2014 649
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
